BiotechTubeBiotechTube
Home/Eli Lilly/Anat Ashkenazi
AA

Anat Ashkenazi

Executive Vice President and Chief Financial Officer

Eli Lilly

Therapeutic Areas

DiabetesOncologyImmunologyNeuroscienceObesityCardiovascular

Eli Lilly Pipeline

DrugIndicationPhase
Tirzepatide (Mounjaro)Type 2 DiabetesApproved
Tirzepatide (Zepbound)ObesityApproved
DonanemabAlzheimer's DiseasePhase 3
MirikizumabUlcerative ColitisPhase 3
LebrikizumabAtopic DermatitisPhase 3
OrforglipronType 2 DiabetesPhase 3
PirtobrutinibB-cell MalignanciesPhase 3
RetifanlimabVarious CancersPhase 2/3

Leadership Team at Eli Lilly

DA
David A. Ricks
Chairman and Chief Executive Officer
DM
Daniel M. Skovronsky
Chief Scientific and Medical Officer, President of Lilly Research Laboratories
AE
Anne E. White
Executive Vice President and President of Lilly International
PJ
Patrik Jonsson
Executive Vice President, President of Lilly USA
IY
Ilya Yuffa
Executive Vice President and President of Lilly Manufacturing Operations
CS
Christi Shaw
Executive Vice President and President of Lilly Oncology
MM
Mike Mason
Executive Vice President and President of Lilly Diabetes
RG
Ruth Gimmi
Executive Vice President, Chief Information and Digital Officer
MB
Melissa Barnes
Executive Vice President, Global Quality
View full Eli Lilly profile